BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34200095)

  • 1. Gut Serpinome: Emerging Evidence in IBD.
    Mkaouar H; Mariaule V; Rhimi S; Hernandez J; Kriaa A; Jablaoui A; Akermi N; Maguin E; Lesner A; Korkmaz B; Rhimi M
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases.
    Mkaouar H; Akermi N; Mariaule V; Boudebbouze S; Gaci N; Szukala F; Pons N; Marquez J; Gargouri A; Maguin E; Rhimi M
    Microb Cell Fact; 2016 Nov; 15(1):201. PubMed ID: 27894344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation.
    Kriaa A; Jablaoui A; Mkaouar H; Akermi N; Maguin E; Rhimi M
    FASEB J; 2020 Jun; 34(6):7270-7282. PubMed ID: 32307770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice.
    Kriaa A; Jablaoui A; Rhimi S; Soussou S; Mkaouar H; Mariaule V; Gruba N; Gargouri A; Maguin E; Lesner A; Rhimi M
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Serine Protease Profiling in Inflammatory Bowel Diseases.
    Jablaoui A; Kriaa A; Mkaouar H; Akermi N; Soussou S; Wysocka M; Wołoszyn D; Amouri A; Gargouri A; Maguin E; Lesner A; Rhimi M
    Front Cell Infect Microbiol; 2020; 10():21. PubMed ID: 32117798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteolytic activity in inflammatory bowel disease: insight from gut microbiota.
    Hou JJ; Ding L; Yang T; Yang YF; Jin YP; Zhang XP; Ma AH; Qin YH
    Microb Pathog; 2024 Mar; 188():106560. PubMed ID: 38272327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
    Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
    World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Dietary Nutrients in Inflammatory Bowel Disease.
    Sugihara K; Morhardt TL; Kamada N
    Front Immunol; 2018; 9():3183. PubMed ID: 30697218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
    Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and inflammatory bowel disease.
    Chen L; Wang J
    WIREs Mech Dis; 2022 Mar; 14(2):e1540. PubMed ID: 35266651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Autophagy in Intestinal Epithelial Cells Alters Gut Microbiota and Host Immune Responses.
    Yang L; Liu C; Zhao W; He C; Ding J; Dai R; Xu K; Xiao L; Luo L; Liu S; Li W; Meng H
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiota heterogeneity and assembly changes associated with the IBD.
    Sun Y; Li L; Xia Y; Li W; Wang K; Wang L; Miao Y; Ma S
    Sci Rep; 2019 Jan; 9(1):440. PubMed ID: 30679676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.